We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

124 hedge funds and large institutions have $42.6M invested in TherapeuticsMD in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 43 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more call options, than puts

Call options by funds: $183K | Put options by funds: $93K

0.09% less ownership

Funds ownership: 0.58% → 0.49% (-0.09%)

3% less capital invested

Capital invested by funds: $44M → $42.6M (-$1.48M)

5% less funds holding

Funds holding: 131 → 124 (-7)

29% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 21

40% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 43

Holders
124
Holders Change
-7
Holders Change %
-5.34%
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
26
Reduced
43
Closed
21
Calls
$183K
Puts
$93K
Net Calls
+$90K
Net Calls Change
-$140K

Top Buyers

Rank Fund Capital Flow
1
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$1.08M
2
Goldman Sachs
Goldman Sachs
New York
+$791K
3
Renaissance Technologies
Renaissance Technologies
New York
+$702K
4
PVI
Pura Vida Investments
New York
+$509K
5
Stifel Financial
Stifel Financial
Missouri
+$285K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.3M
2
Ameriprise
Ameriprise
Minnesota
-$1.84M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$843K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$372K
5
Nomura Holdings
Nomura Holdings
Japan
-$322K
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
126
SG Americas Securities
New York
– -$32K -1,808 Closed
N
127
Natixis
France
– -$28K -1,600 Closed
SWM
128
Spire Wealth Management
Virginia
– -$25K -1,400 Closed
RWM
129
Ritholtz Wealth Management
New York
– -$21K -1,160 Closed
BC
130
Birchview Capital
Vermont
– -$18K -1,000 Closed
MC
131
Manteio Capital
New Jersey
– -$4K -232 Closed
FIM
132
Freedom Investment Management
Connecticut
– -$4K -208 Closed
Parallax Volatility Advisers
133
Parallax Volatility Advisers
California
– -$1K -52 Closed
MCM
134
MV Capital Management
Maryland
– -$1K -40 Closed
EWM
135
Edge Wealth Management
New York
– -$1K -17 Closed
PP
136
PrairieView Partners
Minnesota
– +$16 +1 New
SPIA
137
Steward Partners Investment Advisory
New York
– +$16 +1 +9%
CSS
138
Cubist Systematic Strategies
Connecticut
– +$47 +3 +17%
HR
139
Howe & Rusling
New York
– +$94 +6 +43%
FWM
140
Focused Wealth Management
New York
– +$126 +8 +100%
2 3 4 5
6

TXMD Hedge Fund Activity: Q1 2022 in Review

124 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2022, worth a combined $42.6M — down 3.4% from $44M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of TXMD and 15 opened new positions — a net loss of 6 holders — while 43 trimmed existing stakes and 26 added.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $1.08M. The largest seller was Fidelity Investments, cutting an estimated $4.3M.

  • 124 institutional investors held TherapeuticsMD (TXMD) as of Q1 2022, down from 131 in Q4 2021.
  • Funds reported $42.6M of TherapeuticsMD stock for Q1 2022, down 3.4% quarter-over-quarter.
  • 15 funds opened new TherapeuticsMD positions in Q1 2022 and 21 closed out, a net change of -6 holders.
  • The largest TherapeuticsMD buyer in Q1 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $1.08M added.
  • The largest TherapeuticsMD seller in Q1 2022 was Fidelity Investments, an estimated $4.3M sold.

Based on aggregated 13F filings for Q1 2022.